Goldstein, Cory E. https://orcid.org/0000-0002-0229-5039
du Toit, Jessica
Murphy, Nicholas B.
Nicholls, Stuart G.
Shaw, Julia F.
Althabe, Fernando
Binik, Ariella
Brehaut, Jamie
Eldridge, Sandra
Ferrand, Rashida A.
Gillies, Katie
Giraudeau, Bruno
van der Graaf, Rieke
Hemkens, Lars G.
Hemming, Karla
Johri, Mira
Kim, Scott Y. H.
Largent, Emily
London, Alex John
Mbuagbaw, Lawrence
Mitchell, Susan L.
Smith, Maureen
Tugwell, Peter
Treweek, Shaun
Welch, Vivian A.
Taljaard, Monica
Weijer, Charles
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-479757)
Article History
Received: 23 October 2024
Accepted: 28 April 2025
First Online: 18 June 2025
Declarations
:
: Not applicable.
: Not applicable.
: CW receives consulting income from Cardialen and Eli Lilly & Company. LGH’s institution (RC2 NB) is supported by Foundation Clinical Neuroimmunology and Neuroscience Basel, and RC2 NB has a contract with Roche for a steering committee participation of LGH. All other authors declare no competing interests.